CD8A and cancer: For example, it is likely that positive responses to ITs that are ultimately dependent on the action of CD8+ cytotoxic T cells (such as ICB, certain adoptive cell transfers, and cancer vaccinations) can be predicted based on the level of CD8+ T cells in the tumor.